BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7033581)

  • 1. The protective effect of lodoxamide on antigen-induced bronchospasm. An orally active antiallergic drug.
    Case RL; Rogers PB; VanArsdel PP; Altman LC
    JAMA; 1982 Feb; 247(5):661-4. PubMed ID: 7033581
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
    Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
    J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
    Parrish RW; Davies BH
    Thorax; 1983 Jun; 38(6):458-62. PubMed ID: 6136101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of antigen-induced bronchoconstriction by lodoxamide ethyl, a new orally active antiallergic drug.
    Katcher ML; Reed CE
    J Allergy Clin Immunol; 1980 Sep; 66(3):223-6. PubMed ID: 7410746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
    Ollier S; Graham VA; Bentley S; Davies RJ
    Clin Allergy; 1982 Nov; 12(6):587-94. PubMed ID: 7151268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD; Bui TC; Bewtra AK; Townley RG
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
    J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of fenoterol on allergen-induced bronchospasm.
    D'Amato G; Schiano M; Balzano G; Cocco G; Melillo G
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():509-12. PubMed ID: 6352311
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of oral zindotrine (MDL-257), a bronchial smooth muscle relaxant, on histamine airways responsiveness in asymptomatic asthmatics.
    Küng M; Bangs SE; Gordon EE; Barker KB; Diamond L
    Ann Allergy; 1987 Sep; 59(3):201-6. PubMed ID: 3307547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of Wy-41,195, an orally effective antiallergic drug in animal models.
    Lewis AJ; Carlson RP; Forster TJ; Chang J; Hand JM; Undem BJ; Buckner CK; Tio C; Sisenwine SF; Daniel WC
    Agents Actions; 1986 Jun; 18(3-4):306-12. PubMed ID: 2428218
    [No Abstract]   [Full Text] [Related]  

  • 12. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
    Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of nifedipine and diltiazem on methacholine-induced bronchospasm in allergic asthma.
    Ferrari M; Olivieri M; De Gasperi M; Lechi A
    Ann Allergy; 1989 Sep; 63(3):196-200. PubMed ID: 2672909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effects of nifedipine, DSCG and salbutamol in bronchospasm induced by ultrasonic mist].
    Mazzarella G; Cammarata A; Nardi S; Grella E
    Arch Monaldi Mal Torace; 1987; 42(2):183-90. PubMed ID: 3155409
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of periodontal disease in beagles with lodoxamide ethyl, an inhibitor of mast cell release.
    Jeffcoat MK; Williams RC; Johnson HG; Wechter WJ; Goldhaber P
    J Periodontal Res; 1985 Sep; 20(5):532-41. PubMed ID: 2934538
    [No Abstract]   [Full Text] [Related]  

  • 17. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F; Gangemi S; Ricciardi L; Cuzzocrea S; Di Lorenzo G
    Allergol Immunopathol (Madr); 1997; 25(5):233-7. PubMed ID: 9395007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of iodoxamide ethyl on allergy skin tests.
    Frigas E; Reed CE
    J Allergy Clin Immunol; 1980 Apr; 65(4):257-62. PubMed ID: 7358942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of allergen-induced bronchospasm in patients with reversible bronchial obstruction by a new xanthone derivative.
    Wüthrich B; Parrott D
    Respiration; 1976; 33(3):231-5. PubMed ID: 778963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiallergic activity of topical lodoxamide on in vivo and in vitro models.
    Ciprandi G; Buscaglia S; Catrullo A; Paolieri F; Riccio AM; Fiorino N; Canonica GW
    Allergy; 1996 Dec; 51(12):946-51. PubMed ID: 9020426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.